Recessive loss‐of‐function variants in DPH1 identified as the molecular cause in a sibling pair previously diagnosed with Fine–Lubinsky syndrome
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63845 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Emily R Waskow und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Intellectual Disability, Siblings. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NHGRI NIH HHS.
Abstract (Originalsprache)
Fine–Lubinsky syndrome is a rare clinically defined syndrome sometimes referred to as brachycephaly, deafness, cataract, microstomia, and impaired intellectual development syndrome. Here we provide a clinical and molecular update for a sibling pair diagnosed with Fine–Lubinsky syndrome. An extensive genetic work‐up, including chromosomal microarray analysis and quad exome sequencing, was nondiagnostic. However, a research reanalysis of their exome sequencing data revealed that both were homozygous for an intronic c.749+39G>A [NM_001383.6] variant in DPH1 . RNAseq analysis performed on RNA from fibroblasts revealed significantly reduced expression of DPH1 transcripts suggestive of abnormal splicing followed by nonsense mediated mRNA decay. Since the phenotypes of this sibling pair were consistent with those associated with the inheritance of biallelic pathogenic variants in DPH1 , they were given a diagnosis of developmental delay with short stature, dysmorphic facial features, and sparse hair 1 (DEDSSH1). This leads us to recommend that all individuals with a clinical diagnosis of Fine–Lubinsky syndrome be screened for variants in DPH1 . The clinical histories of this sibling pair emphasize that hearing loss associated with DEDSSH1 may remit over time and that individuals with DEDSSH1 should be monitored for the development of cardiomyopathy. This case also demonstrates the clinical utility of RNAseq as a means of functionally validating the effects of intronic variants that may affect splicing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- Texas Children's Hospital, Houston, Texas, USA.
- Department of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Lindsay C Burrage, Daryl A Scott
Förderung
- NINDS NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NHGRI NIH HHS
- NIH HHS
- NICHD NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Waskow, E. R., Undiagnosed Diseases Network, Emrick, L. T., Rosenfeld, J. A., Ketkar, S., Burrage, L. C., & Scott, D. A. (2025). Recessive loss‐of‐function variants in DPH1 identified as the molecular cause in a sibling pair previously diagnosed with Fine–Lubinsky syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63845
Vancouver
Waskow ER, Undiagnosed Diseases Network, Emrick LT, Rosenfeld JA, Ketkar S, Burrage LC, et al. Recessive loss‐of‐function variants in DPH1 identified as the molecular cause in a sibling pair previously diagnosed with Fine–Lubinsky syndrome. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63845
BibTeX
@article{Waskow2025,
author = {Waskow, Emily R and Undiagnosed Diseases Network, Undiagnosed Diseases Network and Emrick, Lisa T and Rosenfeld, Jill A and Ketkar, Shamika and Burrage, Lindsay C and Scott, Daryl A},
title = {Recessive loss‐of‐function variants in DPH1 identified as the molecular cause in a sibling pair previously diagnosed with Fine–Lubinsky syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63845}
}
EUVIMED